GENE ONLINE|News &
Opinion
Blog

2025-12-01|

Researchers Develop Flexible Ti₃C₂ MXene Supercapacitors for Wearable Health Monitoring Systems

by GOAI
Share To

Researchers have developed a new health monitoring system that utilizes flexible asymmetric supercapacitors made from two-dimensional Ti₃C₂ MXene. This advancement integrates the unique properties of MXene materials to create a wearable technology capable of personalized health tracking. The study, conducted by Manoharan and Pumera, highlights the potential of this innovation in advancing wearable health monitoring devices.

The research focuses on the synthesis of Ti₃C₂ MXene, a material known for its high conductivity and flexibility, which is combined with other components to form an efficient energy storage device. These supercapacitors are designed to power wearable sensors that monitor various health parameters in real-time. The flexibility of the material allows it to conform to the human body, making it suitable for continuous use in wearable applications. The study emphasizes the role of these supercapacitors in providing reliable energy sources for advanced health monitoring systems while maintaining comfort and durability for users.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: December 1, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
LATEST
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top